EP 3463404 A1 20190410 - COMPOSITION OF PROBIOTICS AND DIGESTIVE ENZYMES AND METHOD OF PREPARING AND USING THE SAME
Title (en)
COMPOSITION OF PROBIOTICS AND DIGESTIVE ENZYMES AND METHOD OF PREPARING AND USING THE SAME
Title (de)
ZUSAMMENSETZUNG AUS PROBIOTIKA UND VERDAUUNGSENZYMEN UND VERFAHREN ZUR HERSTELLUNG UND VERWENDUNG DAVON
Title (fr)
COMPOSITION DE PROBIOTIQUES ET D'ENZYMES DIGESTIVES ET SON PROCÉDÉ DE PRÉPARATION ET D'UTILISATION
Publication
Application
Priority
US 2016033976 W 20160524
Abstract (en)
[origin: WO2017204788A1] Disclosed are compositions and methods useful for improving blood cholesterol profiles in a mammal, particularly for improving metabolism of cholesterol, for reducing the levels of low-density lipoprotein cholesterol (LDL-C) in the blood, increasing the levels of high-density lipoprotein (HDL-C) in the blood, for improving weight loss in a mammal, and/or for enhancing overall cardiovascular health in a mammal. Methods can involve identifying a mammal in need of lowering of blood LDL-C and/or triglyceride concentrations, and administering to said mammal a specific formulation consisting of a blend of probiotics; specifically, Bifidobacterium infantis, Bifidobacterium bifidum, Lactobacillus acidophilus, Lactobacillus salivarius, Lactobacillus plantarum, Lactobacillus rhamnosus, Bifidobacterium longum, Lactobacillus casei, Lactobacillus paracasei, in combination with a blend of digestive enzymes; specifically, amylase, glucoamylase, lipase, bromelain, maltase, lactase, hemicellulase, xylanase, papain, and invertase. Preferably, the aforementioned probiotics and digestive enzymes are combined into capsules and administered to said mammal three times daily to achieve said lowering of LDL-C and triglyceride concentrations in blood.
IPC 8 full level
A61K 35/74 (2015.01); A61K 35/745 (2015.01); A61K 35/747 (2015.01); C12N 1/20 (2006.01)
CPC (source: EP KR US)
A61K 35/74 (2013.01 - EP); A61K 35/745 (2013.01 - EP KR US); A61K 35/747 (2013.01 - EP KR US); A61K 38/465 (2013.01 - EP KR US); A61K 38/47 (2013.01 - EP KR US); A61K 38/4873 (2013.01 - EP KR US); A61K 38/54 (2013.01 - EP KR US); A61P 1/00 (2017.12 - EP); A61P 1/04 (2017.12 - EP); A61P 1/14 (2017.12 - EP); A61P 3/02 (2017.12 - EP); A61P 3/06 (2017.12 - EP); C12Y 301/01003 (2013.01 - EP KR); C12Y 302/01001 (2013.01 - EP KR); C12Y 302/01003 (2013.01 - EP KR); C12Y 302/01004 (2013.01 - EP KR); C12Y 302/01008 (2013.01 - EP KR); C12Y 302/01026 (2013.01 - EP KR); C12Y 302/01108 (2013.01 - EP KR); C12Y 304/22002 (2013.01 - EP KR); C12Y 304/22032 (2013.01 - EP KR); C12Y 301/01003 (2013.01 - US); C12Y 302/01001 (2013.01 - US); C12Y 302/01003 (2013.01 - US); C12Y 302/01004 (2013.01 - US); C12Y 302/01008 (2013.01 - US); C12Y 302/01026 (2013.01 - US); C12Y 302/01108 (2013.01 - US); C12Y 304/22002 (2013.01 - US); C12Y 304/22032 (2013.01 - US)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2017204788 A1 20171130; AU 2016408376 A1 20190117; AU 2016408376 B2 20201022; BR 112018074355 A2 20190306; CA 3025512 A1 20171130; CN 109451727 A 20190308; EP 3463404 A1 20190410; EP 3463404 A4 20200311; IL 263238 A 20181231; JP 2019516775 A 20190620; KR 102380198 B1 20220329; KR 20190015718 A 20190214; MX 2018014500 A 20190415; RU 2018144897 A 20200625; RU 2018144897 A3 20200625; US 2020323929 A1 20201015
DOCDB simple family (application)
US 2016033976 W 20160524; AU 2016408376 A 20160524; BR 112018074355 A 20160524; CA 3025512 A 20160524; CN 201680086942 A 20160524; EP 16903312 A 20160524; IL 26323818 A 20181122; JP 2018562173 A 20160524; KR 20187037308 A 20160524; MX 2018014500 A 20160524; RU 2018144897 A 20160524; US 201616304123 A 20160524